Deferiprone Tablet
Product Images NDC 51672-4196

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Deferiprone (NDC 51672-4196). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Deferiprone 01)

Chemical structure of Deferiprone, showing a pyridinone ring with a ketone (O) at one position, a hydroxyl group (OH), a methyl group (CH3), and a methyl group attached to the nitrogen (N) atom in the ring.*

FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

Deferiprone 500 mg tablets packaging label showing a bottle containing 100 tablets. The label highlights the active ingredient, deferiprone, with a dosage strength of 500 mg per tablet. The label includes storage instructions at 20° to 25°C and a pharmacist note to dispense the medication guide. The manufacturer is listed as Taro Pharmaceutical Industries Ltd., distributed by Taro Pharmaceuticals U.S.A., Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.